{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:15:32Z","timestamp":1793196932783,"version":"4.5.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017521","name":"ESTEVE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mild Hypercotisolism (mH) is associated with increased cardiometabolic risk despite limited clinical signs. Surgery is the first-line treatment, with medical therapies reserved when surgery is not feasible. However, data on its efficacy in mH, particularly for blood pressure (BP) control, remain limited. The aim of the present study was to evaluate the impact of low-dose evening metyrapone on 24-hour ambulatory BP, glucose metabolism, and cortisol circadian rhythm in patients with mH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective, single-centre observational study (NCT05255900), 20 patients with mH were treated with evening metyrapone (250-500\u2005mg\/day) for 24 weeks. Inclusion criteria included cortisol &amp;gt;1.8\u2005\u00b5g\/dL after 1\u2005mg dexamethasone suppression, &amp;lt;2 specific Cushing syndrome related symptoms (ie, easy bruising, facial plethora, proximal myopathy, purple striae) and presence of hypertension or glucose metabolism impairment. BP control, glucometabolic profile, and salivary cortisol rhythms were assessed at baseline, 12, and 24 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At 24 weeks, 40% of patients (8\/20) achieved a predefined clinically significant BP improvement (\u22655\u2005mmHg reduction in mean 24-h systolic BP without therapy escalation). This effect was more pronounced in patients with elevated baseline systolic BP. Glucometabolic control improved in 4 patients, notably in those with type 2 diabetes, with a reduction in HbA1c \u2265 0.5% in two patients without changes in antidiabetic therapy. Metyrapone was well tolerated, with no adverse events or adrenal insufficiency reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Low-dose evening metyrapone appears to be a safe and potentially effective option for improving BP control in patients with mH, especially those with higher baseline systolic pressure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf216","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:11:40Z","timestamp":1760530300000},"page":"544-553","source":"Crossref","is-referenced-by-count":8,"title":["Effects of metyrapone in patients with mild hypercortisolism"],"prefix":"10.1093","volume":"193","author":[{"given":"Antonio","family":"Musolino","sequence":"first","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan , Milan 20100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Favero","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan , Milan 20100 ,","place":["Italy"]},{"name":"Unit of Endocrinology, ASST Grande Ospedale Metropolitano Niguarda , Milan 20162 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Parazzoli","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan , Milan 20100 ,","place":["Italy"]},{"name":"Unit of Endocrinology, ASST Grande Ospedale Metropolitano Niguarda , Milan 20162 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Aresta","sequence":"additional","affiliation":[{"name":"Unit of Endocrinology, ASST Grande Ospedale Metropolitano Niguarda , Milan 20162 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Testa","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan , Milan 20100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2068-9581","authenticated-orcid":false,"given":"Luca","family":"Persani","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan , Milan 20100 ,","place":["Italy"]},{"name":"Endocrinology Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano , Milan 20100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8140-3175","authenticated-orcid":false,"given":"Sabrina","family":"Corbetta","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan , Milan 20100 ,","place":["Italy"]},{"name":"Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan 20100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7594-3300","authenticated-orcid":false,"given":"Iacopo","family":"Chiodini","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan , Milan 20100 ,","place":["Italy"]},{"name":"Unit of Endocrinology, ASST Grande Ospedale Metropolitano Niguarda , Milan 20162 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Morelli","sequence":"additional","affiliation":[{"name":"Endocrinology Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano , Milan 20100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"issue":"1\u20133","key":"2025111722563732200_lvaf216-B1","first-page":"30","article-title":"Psychiatric symptoms in Cushing's syndrome: a systematic review","volume":"17","author":"Lin","year":"2020","journal-title":"Innov Clin Neurosci"},{"issue":"5","key":"2025111722563732200_lvaf216-B2","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1530\/EJE-22-0454","article-title":"Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool","volume":"187","author":"Minnetti","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"2025111722563732200_lvaf216-B3","doi-asserted-by":"publisher","first-page":"426108","DOI":"10.3389\/fendo.2018.00805","article-title":"Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing's syndrome: a systematic meta-analysis","volume":"9","author":"Wagner","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2025111722563732200_lvaf216-B4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/MED.0000000000000537","article-title":"Glucose metabolism in Cushing syndrome","volume":"27","author":"Sharma","year":"2020","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"6","key":"2025111722563732200_lvaf216-B5","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s11102-024-01427-7","article-title":"Cushing's disease and bone","volume":"27","author":"Zdrojowy-We\u0142na","year":"2024","journal-title":"Pituitary"},{"issue":"8","key":"2025111722563732200_lvaf216-B6","doi-asserted-by":"publisher","first-page":"e13175","DOI":"10.1111\/jne.13175","article-title":"Cardiovascular complications of Cushings syndrome: impact on morbidity and mortality","volume":"34","author":"Clayton","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"12","key":"2025111722563732200_lvaf216-B7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"2025111722563732200_lvaf216-B8","doi-asserted-by":"publisher","first-page":"e13114","DOI":"10.1111\/jne.13114","article-title":"Clinical presentation and etiology of Cushing's syndrome: data from ERCUSYN","volume":"34","author":"Valassi","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"3","key":"2025111722563732200_lvaf216-B9","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1210\/clinem\/dgz136","article-title":"Time to diagnosis in Cushing's syndrome: a meta-analysis based on 5367 patients","volume":"105","author":"Rubinstein","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025111722563732200_lvaf216-B10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2025111722563732200_lvaf216-B11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","article-title":"Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center","volume":"58","author":"Patrova","year":"2017","journal-title":"Endocrine"},{"issue":"7","key":"2025111722563732200_lvaf216-B12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"2025111722563732200_lvaf216-B13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-024-00984-y","article-title":"Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches","volume":"20","author":"Prete","year":"2024","journal-title":"Nat Rev Endocrinol."},{"issue":"1","key":"2025111722563732200_lvaf216-B14","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European network for the study of adrenal tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025111722563732200_lvaf216-B15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/ejendo\/lvae127","article-title":"Frequency of clinical signs in patients with Cushing's syndrome and mild autonomous cortisol secretion: overlap is common","volume":"191","author":"Braun","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2025111722563732200_lvaf216-B16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/ejendo\/lvad069","article-title":"Determinants of muscle function and health-related quality of life in patients with endogenous hypercortisolism: a cross-sectional study","volume":"189","author":"Li","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2025111722563732200_lvaf216-B17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S2213-8587(25)00062-2","article-title":"Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trial","volume":"13","author":"Tabarin","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6):","key":"2025111722563732200_lvaf216-B18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/SLA.0000000000006183","article-title":"Adrenalectomy improves body weight, glucose, and blood pressure control in patients with mild autonomous cortisol secretion","volume":"279","author":"Koh","year":"2023","journal-title":"Ann Surg"},{"key":"2025111722563732200_lvaf216-B19","doi-asserted-by":"publisher","first-page":"e898084","DOI":"10.3389\/fendo.2022.898084","article-title":"Adrenalectomy improves blood pressure and metabolic control in patients with possible autonomous cortisol secretion: results of a RCT","volume":"13","author":"Morelli","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Supplement_1","key":"2025111722563732200_lvaf216-B20","doi-asserted-by":"publisher","first-page":"A515","DOI":"10.1210\/jendso\/bvab048.1053","article-title":"Metyrapone treatment in endogenous Cushing's syndrome: results at week 12 from PROMPT, a prospective international multicenter, open-label, phase III\/IV study","volume":"5","author":"Nieman","year":"2021","journal-title":"J Endocr Soc"},{"issue":"3","key":"2025111722563732200_lvaf216-B21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s12020-018-1675-4","article-title":"Metyrapone treatment in Cushing's syndrome: a real-life study","volume":"62","author":"Ceccato","year":"2018","journal-title":"Endocrine"},{"issue":"3):","key":"2025111722563732200_lvaf216-B22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/ejendo\/lvaf181","article-title":"Prospective study of metyrapone in endogenous Cushing's syndrome (PROMPT)","volume":"193","author":"Nieman","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2025111722563732200_lvaf216-B23","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1210\/jc.2015-2616","article-title":"Effectiveness of metyrapone in treating Cushing's syndrome: a retrospective multicenter study in 195 patients","volume":"100","author":"Daniel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025111722563732200_lvaf216-B24","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1210\/jc.2017-00823","article-title":"Resetting the abnormal circadian cortisol rhythm in adrenal incidentaloma patients with mild autonomous cortisol secretion","volume":"102","author":"Debono","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025111722563732200_lvaf216-B25","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf206","article-title":"Chronotherapy with once-daily osilodrostat improves cortisol rhythm, quality of life, and sleep in Cushing's syndrome","author":"Ferrari","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2025111722563732200_lvaf216-B26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"6","key":"2025111722563732200_lvaf216-B27","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"issue":"38","key":"2025111722563732200_lvaf216-B28","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"Supplement_1","key":"2025111722563732200_lvaf216-B29","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"Classification and diagnosis of diabetes: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"2025111722563732200_lvaf216-B30","doi-asserted-by":"publisher","first-page":"101521","DOI":"10.1016\/j.beem.2021.101521","article-title":"Epidemiology and mortality of Cushing's syndrome","volume":"35","author":"Hakami","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"2025111722563732200_lvaf216-B31","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1210\/jcem-18-8-906","article-title":"Alterations of adrenal steroid patterns in man resulting from treatment with a chemical inhibitor of 11 \u03b2-hydroxylation","volume":"18","author":"Liddle","year":"1958","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025111722563732200_lvaf216-B32","doi-asserted-by":"publisher","first-page":"e963","DOI":"10.1210\/clinem\/dgad251","article-title":"Evidence of persistent mild hypercortisolism in patients medically treated for cushing disease: the haircush study","volume":"108","author":"Mohammedi","year":"2023","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf216\/64720184\/lvaf216.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/5\/544\/64720184\/lvaf216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/5\/544\/64720184\/lvaf216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T03:56:45Z","timestamp":1763438205000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/193\/5\/544\/8287916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf216","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,10,16]]}}}